Skip to main content

Table 4 2014 prevalencea of pregnancy and underlying health conditions among women aged 11–49 years, N = 1,181,840

From: UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records

  Scotland N = 205,542 Northern Ireland N = 55,559 Wales N = 177,412 England N = 743,327
Among all women aged 11–49 years n Point prevalence /100,000 (95% CI) n Point prevalence /100,000 (95% CI) n Point prevalence /100,000 (95% CI) n Point prevalence /100,000 (95% CI)
Pregnant or any underlying health conditionb 34,051 16,566 (16,406–16,728) 9234 16,620 (16,311–16,932) 31,140 17,552 (17,376–17,730) 117,680 15,832 (15,749–15,915)
Any underlying health conditionb 31,389 15,271 (15,116–15,428) 8317 14,970 (14,674–15,269) 28,733 16,196 (16,024–16,368) 102,121 13,738 (13,660–13,817)
Pregnant 3067 1492 (1440–1545) 1069 1924 (1811–2042) 2834 1597 (1540–1657) 17,755 2389 (2354–2424)
Prevalence of underlying health conditions, b stratified by pregnancy status, among women aged 11–49 years
Pregnant with an underlying health conditionb 405 13,205 (12,026–14,455) 152 14,219 (12,179–16,458) 427 15,067 (13,769–16,458) 2196 12,368 (11,887–12,862)
Not pregnant, with an underlying health conditionb 30,984 15,303 (15,146–15,460) 8165 14,984 (14,686–15,287) 28,306 16,214 (16,041–16,388) 99,925 13,772 (13,693–13,851)
  1. 95% CI 95% confidence interval.
  2. a Point prevalence on 5 March 2014.
  3. b Underlying health conditions comprised: any history of chronic respiratory disease other than asthma, heart disease, kidney disease, neurological conditions such as multiple sclerosis, diabetes mellitus; or current asthma, severe obesity, or immunosuppression; assessed at each index date.